SONM (DNA X, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by SONM officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-10 | MICHAEL C MULICA | Acting CEO | A | — | — |
| 2026-02-10 | Clayton Crolius | Chief Financial Officer | A | — | — |
| 2025-06-30 | LAURENCE W LYTTON | 10%+ Owner | Sell | — | — |
| 2025-04-25 | Charles Becher | See Remarks | Sell | — | — |
| 2025-04-25 | Jack Steenstra | Director | Sell | — | — |
| 2025-04-25 | James S Cassano | Director | Sell | — | — |
| 2025-04-25 | MICHAEL C MULICA | Director | Sell | — | — |
| 2025-04-25 | Jeffrey Wang | Director | Sell | — | — |
| 2025-04-25 | Clayton Crolius | Chief Financial Officer | Sell | — | — |
| 2025-04-02 | Jack Steenstra | Director | A | — | — |
| 2025-04-02 | James S Cassano | Director | A | — | — |
| 2025-04-02 | MICHAEL C MULICA | Director | A | — | — |
| 2025-02-10 | Hao Peter Liu | Chief Executive Officer | A | — | — |
| 2025-02-10 | Clayton Crolius | Chief Financial Officer | A | — | — |
| 2025-02-10 | Charles Becher | See Remarks | A | — | — |
| 2024-11-14 | MICHAEL C MULICA | Director | MIXED | — | — |
| 2024-07-23 | Jack Steenstra | Director | Sell | — | — |
| 2024-07-23 | James S Cassano | Director | Sell | — | — |
| 2024-07-23 | Jeffrey Wang | Director | Sell | — | — |
| 2024-06-24 | Jack Steenstra | Director | MIXED | — | — |
| 2024-06-24 | James S Cassano | Director | MIXED | — | — |
| 2024-06-24 | MICHAEL C MULICA | Director | MIXED | — | — |
| 2024-06-24 | Jeffrey Wang | Director | MIXED | — | — |
| 2024-04-09 | Clayton Crolius | Chief Financial Officer | A | — | — |
| 2024-01-10 | MICHAEL C MULICA | Director | A | — | — |
| 2023-12-28 | Charles Becher | See Remarks | M | — | — |
| 2023-11-27 | Clayton Crolius | Chief Financial Officer | A | — | — |
| 2023-09-29 | James S Cassano | Director | A | — | — |
| 2023-09-29 | Jeffrey Wang | Director | A | — | — |
| 2023-09-29 | MICHAEL C MULICA | Director | A | — | — |
| 2023-09-29 | Jack Steenstra | Director | A | — | — |
| 2023-09-18 | Clayton Crolius | Chief Financial Officer | Buy | — | — |
| 2023-08-23 | Hao Peter Liu | Chief Executive Officer | M | — | — |
| 2023-03-28 | Alan B Howe | Director | Buy | — | — |
| 2023-01-31 | Clayton Crolius | Chief Financial Officer | A | — | — |
| 2022-11-22 | James S Cassano | Director | A | — | — |
| 2022-11-21 | Jeffrey Wang | Director | A | — | — |
| 2022-11-21 | Hao Peter Liu | Chief Executive Officer | A | — | — |
| 2022-11-21 | Jack Steenstra | Director | A | — | — |
| 2022-11-21 | Jose Carlos Principe | Director | A | — | — |
| 2022-11-21 | MICHAEL C MULICA | Director | A | — | — |
| 2022-11-21 | Alan B Howe | Director | A | — | — |
| 2022-10-14 | Jack Steenstra | Director | A | — | — |
| 2022-10-14 | Jose Carlos Principe | Director | A | — | — |
| 2022-10-14 | James S Cassano | Director | A | — | — |
| 2022-10-14 | Jeffrey Wang | Director | A | — | — |
| 2022-08-10 | AJP Holding Company, LLC | 10%+ Owner | Buy | — | — |
| 2022-08-09 | Jose Carlos Principe | Director | A | — | — |
| 2022-08-09 | MICHAEL C MULICA | Director | A | — | — |
| 2022-08-09 | James S Cassano | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 109,313 | — |
| — | 10%+ Owner | 108,130 | — |
| — | Acting CEO | 54,071 | — |
| — | 10%+ Owner | 44,444 | — |
| — | Chief Financial Officer | 36,719 | — |
| — | Chief Executive Officer | 14,966 | — |
| — | 10%+ Owner | 4,703 | — |
| — | See Remarks | 3,482 | — |
| — | Director | 2,730 | — |
| — | Director | 2,729 | — |
| — | Former President, CFO & COO | 1,748 | — |
| — | 10%+ Owner | 1,664 | — |
| — | 10%+ Owner | 1,613 | — |
| — | Director | 980 | — |
| — | Director | 830 | — |
| — | Director | 714 | — |
| — | 10%+ Owner | 650 | — |
| — | 10%+ Owner | 647 | — |
| — | Chief Executive Officer | 293 | — |
| — | Chief Executive Officer | 280 | — |
| — | Director | 223 | — |
| — | Director | 221 | — |
| — | Director | 66 | — |
| — | Director | 66 | — |
| — | Director | 37 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SONM quote page; the site-wide leaderboard is on the insider transactions hub.